2015
DOI: 10.1007/s00384-015-2267-x
|View full text |Cite
|
Sign up to set email alerts
|

Sphincterotomy for anal fissure in Crohn’s disease: is it dangerous?

Abstract: Dear Editor: Lateral internal sphincterotomy (LIS) for anal fissure (AF) in Crohn's disease (CD) has always been considered harmful. Most authors suggest that LIS should be reserved to carefully selected patients with persistent pain, without active rectal disease. We reviewed the literature in order to precise the real risk of complication after LIS for AF in CD patients. Only six retrospective studies including 48 patients were identified. The AF healing rate was 83 %. None experienced impairment of continen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…In CD patients, lateral internal sphincterotomy is almost never appropriate secondary to high rates of complications. 9 In Crohn's patients, idiopathic fissures can be managed with the same approach as non-Crohn's patients, although disease-specific data are limited. Atypical fissures, i.e., those related directly to Crohn's inflammation, are challenging to treat.…”
Section: Medical Managementmentioning
confidence: 99%
“…In CD patients, lateral internal sphincterotomy is almost never appropriate secondary to high rates of complications. 9 In Crohn's patients, idiopathic fissures can be managed with the same approach as non-Crohn's patients, although disease-specific data are limited. Atypical fissures, i.e., those related directly to Crohn's inflammation, are challenging to treat.…”
Section: Medical Managementmentioning
confidence: 99%
“…Healing rate was 83%. However, 40% of patients suffered from postoperative complications, including patients without active rectal luminal disease (22). Targeted surgical treatment of primary APLCD should therefore be reserved for carefully selected symptomatic patients, refractory to medical treatment and preferably restricted to patients with well-controlled luminal disease activity (4,5,8,12).…”
Section: Clinical Presentation and Diagnostic Evaluationmentioning
confidence: 99%